During the past decade, Olympic Ophthalmics conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Olympic Ophthalmics" are "Dry Eye" (1 trials) and "Dry Eye Syndromes" (1 trials). Many other conditions were trialed in "Olympic Ophthalmics" in a lesser frequency.

Most popular intervention types in "Olympic Ophthalmics" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "iTEAR100" (1 trials) and "iTEAR100 treatment" (1 trials). Other intervention names were less common.

The vast majority of trials in "Olympic Ophthalmics" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Olympic Ophthalmics". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Olympic Ophthalmics, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Olympic Ophthalmics, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".